455152841	455152841	CD	B-NP	O
|	|	NNP	I-NP	O
WH	WH	NNP	I-NP	O
|	|	VBD	B-VP	O
25569234	25569234	CD	B-NP	O
|	|	NN	I-NP	O
|	|	NN	I-NP	O
688762	688762	CD	B-NP	O
|	|	CC	I-NP	O
11/20/1993	11/20/1993	CD	I-NP	O
12	12	CD	I-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
AM	AM	VBP	B-VP	O
|	|	JJ	B-NP	O
Discharge	Discharge	NNP	I-NP	O
Summary	Summary	NNP	I-NP	O
|	|	NNP	I-NP	O
Signed	Signed	NNP	I-NP	O
|	|	NNP	I-NP	O
DIS	DIS	NNP	I-NP	O
|	|	NNP	I-NP	O
Admission	Admission	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
8/9/1993	8/9/1993	CD	B-NP	O
Report	Report	NNP	I-NP	O
Status	Status	NNP	I-NP	O
:	:	:	O	O
Signed	Signed	NNP	B-NP	O
Discharge	Discharge	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
2/19/1993	2/19/1993	CD	B-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
DIAGNOSIS	DIAGNOSIS	NN	I-NP	O
:	:	:	O	O
1	1	CD	B-NP	O
-RRB-	-RRB-	NN	I-NP	O
PAROXYSMAL	PAROXYSMAL	NN	I-NP	O
ATRIAL	ATRIAL	NN	I-NP	O
FIBRILLATION	FIBRILLATION	NN	I-NP	O
.	.	.	O	O

2	2	CD	B-NP	O
-RRB-	-RRB-	NNP	I-NP	O
DIABETES	DIABETES	NNP	I-NP	O
MELLITUS	MELLITUS	NNP	I-NP	O
.	.	.	O	O

3	3	CD	B-NP	O
-RRB-	-RRB-	HYPH	I-NP	O
HYPERTENSION	HYPERTENSION	NN	I-NP	O
.	.	.	O	O

HISTORY	HISTORY	NN	B-NP	O
OF	OF	IN	B-PP	O
PRESENT	PRESENT	JJ	B-NP	O
ILLNESS	ILLNESS	NN	I-NP	O
:	:	:	O	O
This	This	DT	B-NP	O
is	be	VBZ	B-VP	O
a	a	DT	B-NP	O
72	72	CD	I-NP	O
year	year	NN	I-NP	O
old	old	JJ	I-NP	O
female	female	NN	I-NP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
history	history	NN	I-NP	O
of	of	IN	B-PP	O
paroxysmal	paroxysmal	JJ	B-NP	O
atrial	atrial	JJ	I-NP	O
fibrillation	fibrillation	NN	I-NP	O
who	who	WP	B-NP	O
has	have	VBZ	B-VP	O
been	be	VBN	I-VP	O
intolerant	intolerant	JJ	B-ADJP	O
of	of	IN	B-PP	O
Quinidine	Quinidine	NN	B-NP	O
and	and	CC	I-NP	O
Procainamide	Procainamide	NN	I-NP	O
and	and	CC	O	O
is	be	VBZ	B-VP	O
admitted	admit	VBN	I-VP	O
for	for	IN	B-PP	O
initiation	initiation	NN	B-NP	O
of	of	IN	B-PP	O
Disopyramide	Disopyramide	NN	B-NP	O
and	and	CC	I-NP	O
Digoxin	Digoxin	NN	I-NP	O
treatment	treatment	NN	I-NP	O
.	.	.	O	O

Patient	Patient	NN	B-NP	O
has	have	VBZ	B-VP	O
a	a	DT	B-NP	O
history	history	NN	I-NP	O
of	of	IN	B-PP	O
Insulin	Insulin	NN	B-NP	B-protein
dependent	dependent	JJ	I-NP	O
diabetes	diabete	NNS	I-NP	O
mellitus	mellitus	NN	I-NP	O
,	,	,	O	O
hypertension	hypertension	NN	B-NP	O
,	,	,	O	O
and	and	CC	O	O
many	many	JJ	B-NP	O
years	year	NNS	I-NP	O
of	of	IN	B-PP	O
paroxysmal	paroxysmal	JJ	B-NP	O
atrial	atrial	JJ	I-NP	O
fibrillation/flutter	fibrillation/flutter	NN	I-NP	O
.	.	.	O	O

In	In	IN	B-PP	O
September	September	NNP	B-NP	O
1992	1992	CD	I-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
began	begin	VBD	B-VP	O
having	have	VBG	I-VP	O
prolonged	prolong	VBN	I-VP	O
,	,	,	O	O
that	that	WDT	B-NP	O
is	be	VBZ	B-VP	O
up	up	IN	B-NP	O
to	to	TO	I-NP	O
thirty	thirty	CD	I-NP	O
to	to	TO	I-NP	O
sixty	sixty	CD	I-NP	O
minute	minute	NN	I-NP	O
,	,	,	O	O
sensations	sensation	NNS	B-NP	O
of	of	IN	B-PP	O
chest	chest	NN	B-NP	O
pounding	pound	VBG	B-VP	O
without	without	IN	B-PP	O
chest	chest	NN	B-NP	O
pain	pain	NN	I-NP	O
,	,	,	O	O
shortness	shortness	NN	B-NP	O
of	of	IN	B-PP	O
breath	breath	NN	B-NP	O
,	,	,	O	O
or	or	CC	O	O
light	light	NN	B-NP	O
headedness	headedness	NN	I-NP	O
.	.	.	O	O

A	A	DT	B-NP	O
Holter	Holter	NNP	I-NP	O
showed	show	VBD	B-VP	O
atrial	atrial	JJ	B-NP	O
premature	premature	JJ	I-NP	O
beats	beat	NNS	I-NP	O
,	,	,	O	O
ventricular	ventricular	JJ	B-NP	O
premature	premature	JJ	I-NP	O
beats	beat	NNS	I-NP	O
,	,	,	O	O
and	and	CC	O	O
supraventricular	supraventricular	JJ	B-NP	O
tachycardia	tachycardia	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
began	begin	VBD	B-VP	O
having	have	VBG	I-VP	O
daily	daily	JJ	B-NP	O
sensations	sensation	NNS	I-NP	O
and	and	CC	O	O
saw	see	VBD	B-VP	O
her	her	PRP$	B-NP	O
primary	primary	JJ	I-NP	O
physician	physician	NN	I-NP	O
,	,	,	O	O
Dr.	Dr.	NNP	B-NP	O
Bleck	Bleck	NNP	I-NP	O
,	,	,	O	O
who	who	WP	B-NP	O
performed	perform	VBD	B-VP	O
an	an	DT	B-NP	O
EKG	EKG	NN	I-NP	B-protein
which	which	WDT	B-NP	O
showed	show	VBD	B-VP	O
atrial	atrial	JJ	B-NP	O
flutter	flutter	NN	I-NP	O
with	with	IN	B-PP	O
an	an	DT	B-NP	O
atrial	atrial	JJ	I-NP	O
rate	rate	NN	I-NP	O
of	of	IN	B-PP	O
300	300	CD	B-NP	O
and	and	CC	O	O
ventricular	ventricular	JJ	B-NP	O
rate	rate	NN	I-NP	O
of	of	IN	B-PP	O
approximately	approximately	RB	B-NP	O
85	85	CD	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
had	have	VBD	B-VP	O
been	be	VBN	I-VP	O
treated	treat	VBN	I-VP	O
on	on	IN	B-PP	O
Diltiazem	Diltiazem	NNP	B-NP	O
which	which	WDT	B-NP	O
was	be	VBD	B-VP	O
changed	change	VBN	I-VP	O
to	to	TO	B-PP	O
Verapamil	Verapamil	NN	B-NP	O
with	with	IN	B-PP	O
discontinuation	discontinuation	NN	B-NP	O
of	of	IN	B-PP	O
her	her	PRP$	B-NP	O
palpitations	palpitation	NNS	I-NP	O
.	.	.	O	O

On	On	IN	B-PP	O
11/12/92	11/12/92	CD	B-NP	O
,	,	,	O	O
she	she	PRP	B-NP	O
had	have	VBD	B-VP	O
an	an	DT	B-NP	O
echo	echo	NN	I-NP	O
which	which	WDT	B-NP	O
showed	show	VBD	B-VP	O
an	an	DT	B-NP	O
ejection	ejection	NN	I-NP	O
fraction	fraction	NN	I-NP	O
of	of	IN	B-PP	O
67	67	CD	B-NP	O
%	%	NN	I-NP	O
,	,	,	O	O
left	leave	VBD	B-VP	O
atrium	atrium	NN	B-NP	O
of	of	IN	B-PP	O
4	4	CD	B-NP	O
cm	cm	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
normal	normal	JJ	B-NP	O
left	left	JJ	I-NP	O
ventricular	ventricular	JJ	I-NP	O
size	size	NN	I-NP	O
and	and	CC	I-NP	O
thickness	thickness	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
sensation	sensation	NN	I-NP	O
of	of	IN	B-PP	O
palpitations	palpitation	NNS	B-NP	O
resumed	resume	VBN	B-VP	O
,	,	,	O	O
however	however	RB	B-ADVP	O
,	,	,	O	O
and	and	CC	O	O
she	she	PRP	B-NP	O
was	be	VBD	B-VP	O
admitted	admit	VBN	I-VP	O
to	to	TO	B-PP	O
Lee	Lee	NNP	B-NP	O
's	's	POS	B-NP	O
County	County	NNP	I-NP	O
Hospital	Hospital	NNP	I-NP	O
on	on	IN	B-PP	O
April	April	NNP	B-NP	O
,	,	,	O	O
1993	1993	CD	B-NP	O
to	to	TO	B-VP	O
begin	begin	VB	I-VP	O
Quinidine	Quinidine	NN	B-NP	O
treatment	treatment	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
started	start	VBD	B-VP	O
Quinidine	Quinidine	NN	B-NP	O
without	without	IN	B-PP	O
complications	complication	NNS	B-NP	O
,	,	,	O	O
however	however	RB	B-ADVP	O
,	,	,	O	O
post-discharge	post-discharge	JJ	B-ADJP	O
,	,	,	O	O
developed	develop	VBN	B-VP	O
headache	headache	NN	B-NP	O
,	,	,	O	O
diarrhea	diarrhea	NN	B-NP	O
,	,	,	O	O
nausea	nausea	NN	B-NP	O
,	,	,	O	O
and	and	CC	O	O
fever	fever	NN	B-NP	O
to	to	TO	B-PP	O
102	102	CD	B-NP	O
on	on	IN	B-PP	O
February	February	NNP	B-NP	O
,	,	,	O	O
1993	1993	CD	B-NP	O
.	.	.	O	O

Therefore	Therefore	RB	B-ADVP	O
,	,	,	O	O
she	she	PRP	B-NP	O
was	be	VBD	B-VP	O
readmitted	readmitte	VBN	I-VP	O
on	on	IN	B-PP	O
August	August	NNP	B-NP	O
,	,	,	O	O
1993	1993	CD	B-NP	O
for	for	IN	B-PP	O
Procainamide	Procainamide	NN	B-NP	O
load	load	NN	I-NP	O
and	and	CC	O	O
was	be	VBD	B-VP	O
discharged	discharge	VBN	I-VP	O
on	on	IN	B-PP	O
a	a	DT	B-NP	O
dose	dose	NN	I-NP	O
of	of	IN	B-PP	O
500	500	CD	B-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	I-NP	O
q.	q.	NN	I-NP	O
6h	6h	NN	I-NP	O
.	.	.	O	O

However	However	RB	B-ADVP	O
,	,	,	O	O
ten	ten	CD	B-NP	O
days	day	NNS	I-NP	O
after	after	IN	B-PP	O
that	that	DT	B-NP	O
,	,	,	O	O
she	she	PRP	B-NP	O
developed	develop	VBD	B-VP	O
arthralgias	arthralgia	NNS	B-NP	O
in	in	IN	B-PP	O
her	her	PRP$	B-NP	O
left	left	JJ	I-NP	O
and	and	CC	I-NP	O
right	right	JJ	I-NP	O
shoulders	shoulder	NNS	I-NP	O
and	and	CC	O	O
right	right	JJ	B-NP	O
elbow	elbow	NN	I-NP	O
and	and	CC	I-NP	O
wrist	wrist	NN	I-NP	O
.	.	.	O	O

Procainamide	Procainamide	NN	B-NP	O
was	be	VBD	B-VP	O
discontinued	discontinue	VBN	I-VP	O
one	one	CD	B-NP	O
week	week	NN	I-NP	O
prior	prior	JJ	B-ADJP	O
to	to	TO	B-PP	O
this	this	DT	B-NP	O
admission	admission	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
denies	deny	VBZ	B-VP	O
any	any	DT	B-NP	O
rash	rash	NN	I-NP	O
,	,	,	O	O
pleuritic	pleuritic	JJ	B-NP	B-protein
chest	chest	NN	I-NP	I-protein
pain	pain	NN	I-NP	I-protein
,	,	,	O	O
nausea	nausea	NN	B-NP	O
,	,	,	O	O
vomiting	vomiting	NN	B-NP	O
,	,	,	O	O
diarrhea	diarrhea	NN	B-NP	O
,	,	,	O	O
constipation	constipation	NN	B-NP	O
,	,	,	O	O
fever	fever	NN	B-NP	O
,	,	,	O	O
dysuria	dysuria	NN	B-NP	O
,	,	,	O	O
orthopnea	orthopnea	NN	B-NP	O
,	,	,	O	O
peripheral	peripheral	JJ	B-NP	O
edema	edema	NN	I-NP	O
,	,	,	O	O
claudication	claudication	NN	B-NP	O
,	,	,	O	O
or	or	CC	O	O
shortness	shortness	NN	B-NP	O
of	of	IN	B-PP	O
breath	breath	NN	B-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
is	be	VBZ	B-VP	O
now	now	RB	I-VP	O
admitted	admit	VBN	I-VP	O
for	for	IN	B-PP	O
Disopyramide	Disopyramide	NN	B-NP	O
and	and	CC	I-NP	O
Digoxin	Digoxin	NN	I-NP	O
initiation	initiation	NN	I-NP	O
and	and	CC	I-NP	O
therapy	therapy	NN	I-NP	O
.	.	.	O	O

PAST	PAST	NNP	B-NP	O
MEDICAL	MEDICAL	NNP	I-NP	O
HISTORY	HISTORY	NNP	I-NP	O
:	:	:	O	O
1	1	CD	B-NP	O
-RRB-	-RRB-	NN	I-NP	O
History	History	NN	I-NP	O
of	of	IN	B-PP	O
deep	deep	JJ	B-NP	O
venous	venous	JJ	I-NP	O
thromboses	thrombos	NNS	I-NP	O
treated	treat	VBN	B-VP	O
with	with	IN	B-PP	O
Heparin	Heparin	NN	B-NP	O
and	and	CC	I-NP	O
Coumadin	Coumadin	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
last	last	JJ	I-NP	O
episode	episode	NN	I-NP	O
was	be	VBD	B-VP	O
twelve	twelve	CD	B-NP	O
years	year	NNS	I-NP	O
ago	ago	RB	B-ADVP	O
.	.	.	O	O

2	2	CD	B-NP	O
-RRB-	-RRB-	HYPH	I-NP	O
History	History	NN	I-NP	O
of	of	IN	B-PP	O
motor	motor	NN	B-NP	O
vehicle	vehicle	NN	I-NP	O
accident	accident	NN	I-NP	O
in	in	IN	B-PP	O
1975	1975	CD	B-NP	O
.	.	.	O	O

3	3	CD	B-NP	O
-RRB-	-RRB-	HYPH	I-NP	O
History	History	NN	I-NP	O
of	of	IN	B-PP	O
exploratory	exploratory	JJ	B-NP	O
laparotomy	laparotomy	NN	I-NP	O
at	at	IN	B-PP	O
age	age	NN	B-NP	O
fourteen	fourteen	CD	I-NP	O
secondary	secondary	JJ	B-ADJP	O
to	to	TO	B-PP	O
``	``	``	O	O
incarcerated	incarcerated	JJ	B-NP	O
colon	colon	NN	I-NP	O
''	''	''	O	O
secondary	secondary	JJ	B-ADJP	O
to	to	TO	B-PP	O
trauma	trauma	NN	B-NP	O
.	.	.	O	O

4	4	CD	B-NP	O
-RRB-	-RRB-	NNP	I-NP	O
Status	Status	NNP	I-NP	O
post	post	NN	I-NP	O
appendectomy	appendectomy	NN	I-NP	O
.	.	.	O	O

5	5	CD	B-NP	O
-RRB-	-RRB-	HYPH	I-NP	O
Diabetes	Diabetes	NN	I-NP	O
times	time	NNS	I-NP	O
twenty	twenty	CD	B-NP	O
years	year	NNS	I-NP	O
,	,	,	O	O
Insulin	Insulin	NN	B-NP	B-protein
dependent	dependent	JJ	I-NP	O
times	time	NNS	I-NP	O
three	three	CD	B-NP	O
years	year	NNS	I-NP	O
.	.	.	O	O

6	6	CD	B-NP	O
-RRB-	-RRB-	NN	I-NP	O
Hypertension	Hypertension	NN	I-NP	O
.	.	.	O	O

ALLERGIES	ALLERGIES	NNS	B-NP	O
:	:	:	O	O
No	No	DT	B-NP	O
known	know	VBN	I-NP	O
drug	drug	NN	I-NP	O
allergies	allergy	NNS	I-NP	O
.	.	.	O	O

CURRENT	CURRENT	NN	B-NP	O
MEDICATIONS	MEDICATIONS	NNS	I-NP	O
:	:	:	O	O
Insulin	Insulin	NNP	B-NP	O
Humulin	Humulin	NNP	I-NP	O
70/30	70/30	CD	I-NP	O
48	48	CD	I-NP	O
units	unit	NNS	I-NP	O
subcutaneously	subcutaneously	RB	B-ADVP	O
q.a.m.	q.a.m.	RB	I-ADVP	O
and	and	CC	O	O
22	22	CD	B-NP	O
units	unit	NNS	I-NP	O
subcutaneously	subcutaneously	RB	B-ADVP	O
q.p.m.	q.p.m.	RB	I-ADVP	O
,	,	,	O	O
Verapamil	Verapamil	NNP	B-NP	O
SR	SR	NNP	I-NP	O
240	240	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	I-NP	O
q.d.	q.d.	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
Procainamide	Procainamide	NNP	B-NP	O
discontinued	discontinue	VBD	B-VP	O
one	one	CD	B-NP	O
week	week	NN	I-NP	O
ago	ago	RB	B-ADVP	O
.	.	.	O	O

SOCIAL	SOCIAL	JJ	B-NP	O
HISTORY	HISTORY	NN	I-NP	O
:	:	:	O	O
She	She	PRP	B-NP	O
is	be	VBZ	B-VP	O
a	a	DT	B-NP	O
home	home	NN	I-NP	O
tutor	tutor	NN	I-NP	O
,	,	,	O	O
she	she	PRP	B-NP	O
is	be	VBZ	B-VP	O
a	a	DT	B-NP	O
retired	retired	JJ	I-NP	O
teacher	teacher	NN	I-NP	O
,	,	,	O	O
lives	live	VBZ	B-VP	O
at	at	IN	B-PP	O
home	home	NN	B-NP	O
with	with	IN	B-PP	O
her	her	PRP$	B-NP	O
husband	husband	NN	I-NP	O
,	,	,	O	O
she	she	PRP	B-NP	O
has	have	VBZ	B-VP	O
seven	seven	CD	B-NP	O
children	child	NNS	I-NP	O
and	and	CC	O	O
thirteen	thirteen	CD	B-NP	O
grandchildren	grandchild	NNS	I-NP	O
,	,	,	O	O
no	no	DT	B-NP	O
tobacco	tobacco	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
no	no	DT	B-NP	O
ethanol	ethanol	NN	I-NP	O
use	use	NN	I-NP	O
.	.	.	O	O

FAMILY	FAMILY	NN	B-NP	O
HISTORY	HISTORY	NN	I-NP	O
:	:	:	O	O
Father	Father	NNP	B-NP	O
deceased	decease	VBD	B-VP	O
at	at	IN	B-PP	O
age	age	NN	B-NP	O
46	46	CD	I-NP	O
with	with	IN	B-PP	O
Streptococcus	Streptococcus	NNP	B-NP	O
viridans	viridan	NNS	I-NP	O
infection	infection	NN	I-NP	O
and	and	CC	I-NP	O
mother	mother	NN	I-NP	O
deceased	decease	VBD	B-VP	O
at	at	IN	B-PP	O
an	an	DT	B-NP	O
early	early	JJ	I-NP	O
age	age	NN	I-NP	O
of	of	IN	B-PP	O
pneumonia	pneumonia	NN	B-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
has	have	VBZ	B-VP	O
a	a	DT	B-NP	O
brother	brother	NN	I-NP	O
deceased	decease	VBN	B-VP	O
from	from	IN	B-PP	O
alcoholism	alcoholism	NN	B-NP	O
and	and	CC	O	O
a	a	DT	B-NP	O
sister	sister	NN	I-NP	O
deceased	decease	VBN	B-VP	O
from	from	IN	B-PP	O
unknown	unknown	JJ	B-NP	O
causes	cause	NNS	I-NP	O
.	.	.	O	O

PHYSICAL	PHYSICAL	JJ	B-NP	O
EXAMINATION	EXAMINATION	NN	I-NP	O
:	:	:	O	O
Temperature	Temperature	NN	B-NP	O
was	be	VBD	B-VP	O
98.8	98.8	CD	B-NP	O
,	,	,	O	O
heart	heart	NN	B-NP	O
rate	rate	NN	I-NP	O
was	be	VBD	B-VP	O
87	87	CD	B-NP	O
,	,	,	O	O
blood	blood	NN	B-NP	O
pressure	pressure	NN	I-NP	O
150/80	150/80	CD	I-NP	O
,	,	,	O	O
respirations	respiration	NNS	B-NP	O
18	18	CD	B-NP	O
,	,	,	O	O
and	and	CC	O	O
she	she	PRP	B-NP	O
was	be	VBD	B-VP	O
81.8	81.8	CD	B-NP	O
kg	kg	NN	I-NP	O
.	.	.	O	O

This	This	DT	B-NP	O
was	be	VBD	B-VP	O
a	a	DT	B-NP	O
well-developed	well-developed	JJ	I-NP	O
,	,	,	I-NP	O
well-nourished	well-nourished	JJ	I-NP	O
pleasant	pleasant	NN	I-NP	O
female	female	NN	I-NP	O
in	in	IN	B-PP	O
no	no	DT	B-NP	O
acute	acute	JJ	I-NP	O
distress	distress	NN	I-NP	O
.	.	.	O	O

HEENT	HEENT	NN	B-NP	O
:	:	:	O	O
Examination	Examination	NN	B-NP	O
showed	show	VBD	B-VP	O
pupils	pupil	NNS	B-NP	O
equal	equal	JJ	B-ADJP	O
,	,	,	O	O
round	round	JJ	B-ADJP	O
,	,	,	O	O
and	and	CC	O	O
reactive	reactive	JJ	B-ADJP	O
to	to	TO	B-PP	O
light	light	NN	B-NP	O
,	,	,	O	O
oropharynx	oropharynx	NN	B-NP	O
clear	clear	JJ	B-ADJP	O
,	,	,	O	O
no	no	DT	B-NP	O
lymphadenopathy	lymphadenopathy	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
2	2	CD	B-NP	O
+	+	SYM	I-NP	O
carotids	carotid	NNS	I-NP	O
bilaterally	bilaterally	RB	B-ADVP	O
with	with	IN	B-PP	O
no	no	DT	B-NP	O
bruits	bruit	NNS	I-NP	O
.	.	.	O	O

CARDIAC	CARDIAC	NN	B-NP	O
:	:	:	O	O
Examination	Examination	NN	B-NP	O
showed	show	VBD	B-VP	O
a	a	DT	B-NP	O
regular	regular	JJ	I-NP	O
rate	rate	NN	I-NP	O
and	and	CC	I-NP	O
rhythm	rhythm	NN	I-NP	O
,	,	,	O	O
distant	distant	JJ	B-NP	O
S1	S1	NN	I-NP	B-protein
and	and	CC	O	O
S2	S2	NN	B-NP	B-protein
,	,	,	O	O
no	no	DT	B-NP	O
murmurs	murmur	NNS	I-NP	O
,	,	,	O	O
gallops	gallop	NNS	B-NP	O
,	,	,	O	O
or	or	CC	O	O
rubs	rub	NNS	B-NP	O
,	,	,	O	O
and	and	CC	O	O
no	no	DT	B-NP	O
jugular	jugular	JJ	I-NP	O
venous	venous	JJ	I-NP	O
distention	distention	NN	I-NP	O
.	.	.	O	O

LUNGS	LUNGS	NN	B-NP	O
:	:	:	O	O
Clear	Clear	JJ	B-ADJP	O
to	to	TO	B-PP	O
auscultation	auscultation	NN	B-NP	O
bilaterally	bilaterally	RB	B-ADVP	O
.	.	.	O	O

ABDOMEN	ABDOMEN	NN	B-NP	O
:	:	:	O	O
Well	Well	NNP	B-NP	O
healed	heal	VBD	B-VP	O
scar	scar	NN	B-NP	O
,	,	,	O	O
positive	positive	JJ	B-NP	O
bowel	bowel	NN	I-NP	O
sounds	sound	NNS	I-NP	O
,	,	,	O	O
soft	soft	JJ	B-NP	O
,	,	,	I-NP	O
non-tender	non-tender	JJ	I-NP	O
,	,	,	O	O
and	and	CC	O	O
no	no	DT	B-NP	O
masses	mass	NNS	I-NP	O
.	.	.	O	O

EXTREMITIES	EXTREMITIES	NNS	B-NP	O
:	:	:	O	O
No	No	DT	B-NP	O
cyanosis	cyanosis	NN	I-NP	O
,	,	,	O	O
clubbing	clubbing	NN	B-NP	O
,	,	,	O	O
or	or	CC	O	O
edema	edema	NN	B-NP	O
,	,	,	O	O
2	2	CD	B-NP	O
+	+	SYM	I-NP	O
bilateral	bilateral	JJ	I-NP	O
dorsalis	dorsalis	NN	I-NP	O
pedis	pedis	NN	I-NP	O
,	,	,	O	O
2	2	CD	B-NP	O
+	+	SYM	I-NP	O
femorals	femoral	NNS	I-NP	O
bilaterally	bilaterally	RB	B-ADVP	O
,	,	,	O	O
and	and	CC	O	O
no	no	DT	B-NP	O
femoral	femoral	JJ	I-NP	O
bruits	bruit	NNS	I-NP	O
.	.	.	O	O

NEUROLOGICAL	NEUROLOGICAL	NN	B-NP	O
:	:	:	O	O
Examination	Examination	NN	B-NP	O
showed	show	VBD	B-VP	O
her	her	PRP	B-NP	O
to	to	TO	B-VP	O
be	be	VB	I-VP	O
alert	alert	JJ	B-ADJP	O
and	and	CC	O	O
oriented	orient	VBN	B-VP	O
times	time	NNS	B-NP	O
three	three	CD	B-NP	O
,	,	,	O	O
cranial	cranial	JJ	B-NP	O
nerves	nerve	NNS	I-NP	O
II-XII	II-XII	NN	I-NP	O
intact	intact	JJ	B-ADJP	O
,	,	,	O	O
and	and	CC	O	O
light	light	NN	B-NP	O
touch	touch	NN	I-NP	O
,	,	,	O	O
joint	joint	JJ	B-NP	O
position	position	NN	I-NP	O
sense	sense	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
vibratory	vibratory	JJ	B-NP	O
sense	sense	NN	I-NP	O
intact	intact	JJ	B-ADJP	O
.	.	.	O	O

Coordination	Coordination	NN	B-NP	O
showed	show	VBD	B-VP	O
finger-to-nose	finger-to-nose	JJ	B-NP	O
and	and	CC	I-NP	O
fine	fine	JJ	I-NP	O
finger	finger	NN	I-NP	O
movements	movement	NNS	I-NP	O
intact	intact	JJ	B-NP	O
,	,	,	I-NP	O
deep	deep	JJ	I-NP	O
tendon	tendon	NN	I-NP	O
reflexes	reflex	NNS	I-NP	O
were	be	VBD	B-VP	O
1	1	CD	B-NP	O
+	+	SYM	I-NP	O
throughout	throughout	NN	I-NP	O
,	,	,	O	O
no	no	DT	B-NP	O
patellar	patellar	NN	I-NP	O
or	or	CC	I-NP	O
ankle	ankle	NN	I-NP	O
reflexes	reflex	NNS	I-NP	O
,	,	,	O	O
and	and	CC	O	O
equivocal	equivocal	JJ	B-NP	O
plantar	plantar	NN	I-NP	O
reflexes	reflex	NNS	I-NP	O
.	.	.	O	O

Muscle	Muscle	NN	B-NP	O
strength	strength	NN	I-NP	O
was	be	VBD	B-VP	O
5/5	5/5	CD	B-NP	O
.	.	.	O	O

LABORATORY	LABORATORY	NN	B-NP	O
EXAMINATION	EXAMINATION	NN	I-NP	O
:	:	:	O	O
Sodium	Sodium	NN	B-NP	O
was	be	VBD	B-VP	O
138	138	CD	B-NP	O
,	,	,	O	O
potassium	potassium	NN	B-NP	O
4.2	4.2	CD	I-NP	O
,	,	,	O	O
BUN	BUN	NN	B-NP	B-DNA
16	16	CD	I-NP	I-DNA
,	,	,	O	O
creatinine	creatinine	NN	B-NP	O
0.9	0.9	CD	I-NP	O
,	,	,	O	O
and	and	CC	O	O
glucose	glucose	NN	B-NP	B-protein
222	222	CD	I-NP	I-protein
.	.	.	O	O

White	White	JJ	B-NP	O
blood	blood	NN	I-NP	O
count	count	NN	I-NP	O
was	be	VBD	B-VP	O
6.8	6.8	CD	B-NP	O
,	,	,	O	O
hematocrit	hematocrit	NN	B-NP	O
was	be	VBD	B-VP	O
39	39	CD	B-NP	O
with	with	IN	B-PP	O
an	an	DT	B-NP	O
MCV	MCV	NN	I-NP	O
of	of	IN	B-PP	O
84.1	84.1	CD	B-NP	O
,	,	,	O	O
RDW	RDW	NNP	B-NP	O
of	of	IN	B-PP	O
12.3	12.3	CD	B-NP	O
,	,	,	O	O
and	and	CC	O	O
platelets	platelet	NNS	B-NP	B-cell_type
224	224	CD	I-NP	O
,	,	,	I-NP	O
000	000	CD	I-NP	O
.	.	.	O	O

Liver	Liver	NN	B-NP	O
function	function	NN	I-NP	O
tests	test	NNS	I-NP	O
were	be	VBD	B-VP	O
normal	normal	JJ	B-ADJP	O
,	,	,	O	O
cholesterol	cholesterol	NN	B-NP	O
was	be	VBD	B-VP	O
119	119	CD	B-NP	O
,	,	,	O	O
triglycerides	triglyceride	NNS	B-NP	O
167	167	CD	B-NP	O
,	,	,	O	O
PT	PT	NN	B-NP	B-protein
was	be	VBD	B-VP	I-protein
11.4	11.4	CD	B-NP	I-protein
,	,	,	O	O
phosphate	phosphate	NN	B-NP	O
was	be	VBD	B-VP	O
3.5	3.5	CD	B-NP	O
,	,	,	O	O
and	and	CC	O	O
calcium	calcium	NN	B-NP	O
was	be	VBD	B-VP	O
9.2	9.2	CD	B-NP	O
.	.	.	O	O

Urinalysis	Urinalysis	NN	B-NP	O
showed	show	VBD	B-VP	O
trace	trace	NN	B-NP	O
glucose	glucose	NN	I-NP	O
and	and	CC	O	O
0-1	0-1	CD	B-NP	O
white	white	JJ	I-NP	B-cell_type
blood	blood	NN	I-NP	I-cell_type
cells	cell	NNS	I-NP	I-cell_type
.	.	.	O	O

EKG	EKG	NN	B-NP	B-protein
showed	show	VBD	B-VP	O
a	a	DT	B-NP	O
normal	normal	JJ	I-NP	O
sinus	sinus	NN	I-NP	O
rhythm	rhythm	NN	I-NP	O
at	at	IN	B-PP	O
75	75	CD	B-NP	O
,	,	,	O	O
intervals	interval	NNS	B-NP	O
0.21	0.21	CD	B-NP	O
/	/	SYM	I-NP	O
0.13	0.13	CD	I-NP	O
/	/	SYM	I-NP	O
0.428	0.428	CD	I-NP	O
,	,	,	O	O
QTC	QTC	NNP	B-NP	O
was	be	VBD	B-VP	O
0.477	0.477	CD	B-NP	O
with	with	IN	B-PP	O
left	left	JJ	B-NP	O
bundle-branch	bundle-branch	NN	I-NP	O
block	block	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
left	leave	VBD	B-VP	O
axis	axis	NN	B-NP	O
deviation	deviation	NN	I-NP	O
.	.	.	O	O

HOSPITAL	HOSPITAL	JJ	B-NP	O
COURSE	COURSE	NN	I-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
admitted	admit	VBN	I-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
Cardiology	Cardiology	NNP	I-NP	O
Ton	Ton	NNP	I-NP	O
Minlilake	Minlilake	NNP	I-NP	O
Er	Er	NNP	I-NP	B-protein
Team	Team	NNP	I-NP	O
and	and	CC	O	O
begun	begin	VBN	B-VP	O
on	on	IN	B-PP	O
Disopyramide	Disopyramide	NN	B-NP	O
at	at	IN	B-PP	O
a	a	DT	B-NP	O
dose	dose	NN	I-NP	O
of	of	IN	B-PP	O
300	300	CD	B-NP	O
mg	mg	NN	I-NP	O
SR	SR	NN	I-NP	O
p.o.	p.o.	FW	B-ADVP	O
b.i.d.	b.i.d.	FW	I-ADVP	O
,	,	,	O	O
the	the	DT	B-NP	O
Verapamil	Verapamil	NN	I-NP	O
was	be	VBD	B-VP	O
discontinued	discontinue	VBN	I-VP	O
,	,	,	O	O
and	and	CC	O	O
she	she	PRP	B-NP	O
was	be	VBD	B-VP	O
loaded	load	VBN	I-VP	O
with	with	IN	B-PP	O
Digoxin	Digoxin	NN	B-NP	O
orally	orally	RB	B-ADVP	O
and	and	CC	I-ADVP	O
then	then	RB	I-ADVP	O
continued	continue	VBN	B-VP	O
on	on	IN	B-PP	O
a	a	DT	B-NP	O
maintenance	maintenance	NN	I-NP	O
dose	dose	NN	I-NP	O
of	of	IN	B-PP	O
0.125	0.125	CD	B-NP	O
mg	mg	NN	I-NP	O
q.d.	q.d.	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
experienced	experience	VBD	B-VP	O
frequent	frequent	JJ	B-NP	O
episodes	episode	NNS	I-NP	O
of	of	IN	B-PP	O
paroxysmal	paroxysmal	JJ	B-NP	O
atrial	atrial	JJ	I-NP	O
flutter/atrial	flutter/atrial	JJ	I-NP	O
fibrillation	fibrillation	NN	I-NP	O
and	and	CC	O	O
the	the	DT	B-NP	O
Disopyramide	Disopyramide	NN	I-NP	O
dose	dose	NN	I-NP	O
was	be	VBD	B-VP	O
increased	increase	VBN	I-VP	O
to	to	TO	B-PP	O
200	200	CD	B-NP	O
mg	mg	NN	I-NP	O
of	of	IN	B-PP	O
immediate	immediate	JJ	B-NP	O
release	release	NN	I-NP	O
q.	q.	NN	I-NP	O
6h	6h	NN	I-NP	O
.	.	.	O	O

p.o.	p.o.	FW	B-NP	O
.	.	.	O	O

However	However	RB	B-ADVP	O
,	,	,	O	O
she	she	PRP	B-NP	O
continued	continue	VBD	B-VP	O
to	to	TO	I-VP	O
have	have	VB	I-VP	O
five	five	CD	B-NP	O
to	to	TO	I-NP	O
ten	ten	CD	I-NP	O
minute	minute	NN	I-NP	O
runs	run	NNS	I-NP	O
of	of	IN	B-PP	O
atrial	atrial	JJ	B-NP	O
fibrillation	fibrillation	NN	I-NP	O
which	which	WDT	B-NP	O
were	be	VBD	B-VP	O
symptomatic	symptomatic	JJ	B-ADJP	O
with	with	IN	B-PP	O
sensation	sensation	NN	B-NP	O
of	of	IN	B-PP	O
palpitations	palpitation	NNS	B-NP	O
and	and	CC	O	O
anxiety	anxiety	NN	B-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
begun	begin	VBN	I-VP	O
on	on	IN	B-PP	O
intravenous	intravenous	JJ	B-NP	O
Heparin	Heparin	NN	I-NP	O
.	.	.	O	O

Because	Because	IN	B-PP	O
of	of	IN	I-PP	O
urinary	urinary	JJ	B-NP	O
retention	retention	NN	I-NP	O
on	on	IN	B-PP	O
disopyramide	disopyramide	NN	B-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
disopyramide	disopyramide	NN	I-NP	O
was	be	VBD	B-VP	O
discontinued	discontinue	VBN	I-VP	O
,	,	,	O	O
and	and	CC	O	O
she	she	PRP	B-NP	O
was	be	VBD	B-VP	O
begun	begin	VBN	I-VP	O
on	on	IN	B-PP	O
Propafenone	Propafenone	NN	B-NP	O
at	at	IN	B-PP	O
150	150	CD	B-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	I-NP	O
q.	q.	NN	I-NP	O
8h	8h	NN	I-NP	O
.	.	.	O	O

After	After	IN	B-PP	O
discontinuation	discontinuation	NN	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
Disopyramide	Disopyramide	NN	I-NP	O
,	,	,	O	O
her	her	PRP$	B-NP	O
QTC	QTC	NN	I-NP	B-protein
came	come	VBD	B-VP	O
down	down	RB	B-ADVP	O
to	to	TO	B-PP	O
0.5	0.5	CD	B-NP	O
and	and	CC	O	O
after	after	IN	B-PP	O
Propafenone	Propafenone	NN	B-NP	O
initiation	initiation	NN	I-NP	O
,	,	,	O	O
she	she	PRP	B-NP	O
was	be	VBD	B-VP	O
also	also	RB	I-VP	O
started	start	VBN	I-VP	O
back	back	RB	B-ADVP	O
on	on	IN	B-PP	O
Verapamil	Verapamil	NN	B-NP	O
80	80	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	I-NP	O
q.	q.	NN	I-NP	O
8h	8h	NN	I-NP	O
.	.	.	O	O

and	and	CC	O	O
the	the	DT	B-NP	O
Digoxin	Digoxin	NN	I-NP	O
was	be	VBD	B-VP	O
discontinued	discontinue	VBN	I-VP	O
.	.	.	O	O

She	She	PRP	B-NP	O
experienced	experience	VBD	B-VP	O
no	no	DT	B-NP	O
further	further	JJ	I-NP	O
episodes	episode	NNS	I-NP	O
of	of	IN	B-PP	O
atrial	atrial	JJ	B-NP	O
fibrillation/flutter	fibrillation/flutter	NN	I-NP	O
prior	prior	JJ	B-ADJP	O
to	to	TO	B-VP	O
discharge	discharge	VB	I-VP	O
.	.	.	O	O

Therefore	Therefore	RB	B-ADVP	O
,	,	,	O	O
her	her	PRP$	B-NP	O
Heparin	Heparin	NN	I-NP	O
was	be	VBD	B-VP	O
discontinued	discontinue	VBN	I-VP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
QT	QT	NN	I-NP	O
was	be	VBD	B-VP	O
0.4	0.4	CD	B-NP	O
and	and	CC	O	O
QRS	QRS	NN	B-NP	B-protein
0.12	0.12	CD	I-NP	I-protein
on	on	IN	B-PP	O
discharge	discharge	NN	B-NP	O
.	.	.	O	O

DISPOSITION	DISPOSITION	NN	B-NP	O
:	:	:	O	O
She	She	PRP	B-NP	O
is	be	VBZ	B-VP	O
to	to	TO	B-VP	O
call	call	VB	I-VP	O
Dr.	Dr.	NNP	B-NP	O
Vieau	Vieau	NNP	I-NP	O
for	for	IN	B-PP	O
a	a	DT	B-NP	O
follow-up	follow-up	JJ	I-NP	O
appointment	appointment	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
is	be	VBZ	B-VP	O
discharged	discharge	VBN	I-VP	O
on	on	IN	B-PP	O
Humulin	Humulin	NNP	B-NP	O
70/30	70/30	CD	I-NP	O
40	40	CD	I-NP	O
units	unit	NNS	I-NP	O
q.a.m.	q.a.m.	NN	I-NP	O
and	and	CC	O	O
22	22	CD	B-NP	O
units	unit	NNS	I-NP	O
q.p.m.	q.p.m.	NN	I-NP	O
,	,	,	O	O
Propafenone	Propafenone	NN	B-NP	O
150	150	CD	I-NP	O
mg	mg	NN	I-NP	O
q.	q.	NN	I-NP	O
8h	8h	NN	I-NP	O
.	.	.	O	O

,	,	,	O	O
and	and	CC	O	O
Verapamil	Verapamil	NN	B-NP	O
SR	SR	NN	I-NP	O
250	250	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	NN	I-NP	O
q.d.	q.d.	NNP	I-NP	O
Dictated	Dictated	NNP	I-NP	O
By	By	NNP	I-NP	O
:	:	:	O	O
JOAQUIN	JOAQUIN	NNP	B-NP	O
B.	B.	NNP	I-NP	O
TRESTER	TRESTER	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
SK94	SK94	NNP	I-NP	O
Attending	Attending	NNP	I-NP	O
:	:	:	O	O
LAWERENCE	LAWERENCE	NNP	B-NP	O
E.	E.	NNP	I-NP	O
ZMUDA	ZMUDA	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
WS2	WS2	NNP	I-NP	O
IS266/3222	IS266/3222	NNP	I-NP	O
Batch	Batch	NNP	I-NP	O
:	:	:	O	O
0973	0973	CD	B-NP	O
Index	Index	NNP	I-NP	O
No	No	NNP	I-NP	O
.	.	.	O	O

EZEHIR87ML	EZEHIR87ML	NN	B-NP	O
D	D	NN	I-NP	O
:	:	:	O	O
1/13/93	1/13/93	CD	B-NP	O
T	T	NN	I-NP	O
:	:	:	O	O
3/1/93	3/1/93	CD	B-NP	O

